海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
507件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- CLINICAL TRIAL OF THE SAFETY AND EFFECTIVENESS OF IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10% SOLUTION (IGIV, 10%) FOR THE TREATMENT OF MILD TO MODERATE ALZHEIMER’S DISEASE (AD)
- Mild to moderate Alzheimer’s disease (AD) MedDRA version: 14.1 Level: HLT Classification code 10001897 Term: Alzheimer's disease (incl subtypes) System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Belgium, Canada, Germany, Israel, Japan, Poland, Spain, United Kingdom, United States
- 2011-09-08
Not recruiting
- The impact of adding healthier food options to fast food menus on parent food selection for themselves and their child.
- Intended energy purchase and consumption of parents and children
- Australia
- 2013-10-09
Recruiting
- A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
- Atopic Dermatitis
- Argentina, Australia, Austria, Canada, Czechia, Denmark, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Swaziland, Switzerland, Taiwan
- 2017-11-03
Not recruiting
- A Safety Study of BTX 1204 Solution in Patients with Atopic Dermatitis
- Atopic Dermatitis
- Australia
- 2017-10-11
Not recruiting
- Influence of Simethicone added to the rinse water during colonoscopies on polyp-detection rates
- need to undergo routine colonoscopy
- Australia
- 2017-08-07
Not recruiting
- Efficacy and Safety of Adding Atracurium to Percaruncular Block for High Myopes Undergoing Cataract Surgery
- Quality of Ocular Akinesia (Onset and Duration);Quality of Ocular Akinesia (Onset and Duration);Quality of Ocular Akinesia (Onset and Duration);Quality of Ocular Akinesia (Onset and Duration)
- Egypt
- 2017-08-02
Not recruiting
- Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
- Atopic Dermatitis
- Australia, Canada, Denmark, Italy, Korea, Republic of, Poland, Russian Federation, United Kingdom, United States
- 2017-05-18
Not recruiting
- Dose-ranging Study of Nemolizumab in Atopic Dermatitis
- Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis
- Australia, Canada, France, Germany, Poland, United States
- 2017-03-29
Recruiting
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age
- Respiratory Syncytial Virus
- Australia, Brazil, Canada, Finland, Germany, New Zealand, Poland, Spain, Sweden, United Kingdom, United States
- 2018-06-20
Not recruiting
- An open label exploratory study of SVT-XCLEAR for mild-to-moderate atopic dermatitis in children and adults
- Atopic Dermatitis;Staphylococcus infection
- Australia
- 2018-06-14